Hi,
A patient might be eligible for Tirzepatide (Mounjaro) from a GP only if they have a BMI of 40 or more and have at least 4 of these weight-related health conditions:
Type 2 diabetes
High blood pressure (hypertension)
Heart disease (cardiovascular disease)
Abnormal blood fats (dyslipidaemia)
Obstructive sleep apnoea
‘Access’ on 23 June does not mean people will be able to get a prescription for Tirzepatide (Mounjaro) on that day.
Access to the medication goes hand in hand with behavioural support and wraparound care. Those who gain access to Tirzepatide (Mounjaro®) on the NHS must also be referred onto a diet and exercise support programme. The structured wraparound care support focuses on good nutrition to support health and increasing physical activity. This support is designed specifically for people receiving Tirzepatide (Mounjaro®) to help them get the most out of their treatment and enhance their ability to achieve and maintain healthy weight loss.
Kind Regards,
Pemberton Surgery.
You can get up to date information on roll-out in Greater Manchester here